1. bookVolume 56 (2022): Issue 1 (January 2022)
Journal Details
First Published
30 Mar 2016
Publication timeframe
4 times per year
access type Open Access

Insulin receptor substrate 1 gene variations and lipid profile characteristics in the type 2 diabetic patients with comorbid obesity and chronic pancreatitis

Published Online: 18 Feb 2022
Volume & Issue: Volume 56 (2022) - Issue 1 (January 2022)
Page range: 1 - 9
Journal Details
First Published
30 Mar 2016
Publication timeframe
4 times per year

Objective. Type 2 diabetes mellitus (T2DM) is one of diseases that develops in a setting of polymorbid processes or more often promotes their development, forming in this spectrum the phenomenon of comorbidity. The aim of this study was to evaluate changes in the lipid panel data in T2DM patients with comorbid obesity and chronic pancreatitis (CP) taking into account the C/A polymorphism of the insulin receptor substrate 1 (IRS1) gene (rs2943640).

Methods. The study involved 34 T2DM patients and 10 healthy individuals. The rs2943640 IRS1 gene polymorphism was genotyped using the TaqMan real-time polymerase chain reaction (PCR) method. Blood serum lipid panel data were determined with commercially available kits on a Cobas 6000 analyzer.

Results. In patients with only T2DM and T2DM + comorbid obesity, an association between IRS1 gene polymorphism (rs2943640) and lipid profile abnormalities with maximum changes of the lipid characteristics recorded in C/C genotype carriers was found. Within the C/C genotype of the IRS1 gene (rs2943640) in type 2 diabetic patients with comorbid obesity and CP, significantly lower high-density lipoprotein cholesterol (HDL-C) levels and significantly higher levels of triglycerides (TG), non-HDL-C and remnant cholesterol (RC) in relation to type 2 diabetic patients with comorbid obesity were found. At the same time, within the C/A genotype of the IRS1 gene (rs2943640), significant changes of lipid panel data were found in type 2 diabetic patients with comorbid obesity relative to the control group (p<0.001).

Conclusions. Our data indicate that the presence of the C allele of IRS1 gene (rs2943640) in both homozygous and heterozygous states may indicate increased risk of dyslipidemia in type 2 diabetic patients with comorbidities.


Almulla M. Location-based expert system for diabetes diagnosis and medication recommendation. Kuwait J Sci 48, 67–77, 2021.10.48129/kjs.v48i1.8687 Search in Google Scholar

Al-Sulaiti H, Diboun I, Agha MV, Mohamed FFS, Atkin S, Domling AS. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. J Transl Med 17, 348, 2019.10.1186/s12967-019-2096-8680529331640727 Search in Google Scholar

American Diabetes Association. Standards of medical care in diabetes–2019 abridged for primary care providers. Clin Diabetes 37, 11–34, 2019.10.2337/cd18-0105633611930705493 Search in Google Scholar

Arikoglu H, Aksoy HM, Erkoc KD, Asik A, Ipekci SH, Iscioglu F. IRS1 gene polymorphisms Gly972Arg and Ala-513Pro are not associated with insulin resistance and type 2 diabetes risk in non-obese Turkish population. Meta Gene 2, 579–585, 2014.10.1016/j.mgene.2014.07.008428784825606440 Search in Google Scholar

Bedair RN, Magour GM, Ooda SA, Amar EM, Awad AM. Insulin receptor substrate-1 G972R single nucleotide polymorphism in Egyptian patients with chronic hepatitis C virus infection and type 2 diabetes mellitus. Egypt Liver Journal 11, 2, 2021.10.1186/s43066-020-00069-1 Search in Google Scholar

Bluher M, Stumvoll M. Diabetes and Obesity. In: Diabetes Complications, Comorbidities and Related Disorders (Bonora E, De Fronzo R. Ed.), Endocrinology, Springer, Cham, 2018.10.1007/978-3-319-44433-8_1 Search in Google Scholar

Chernatska O, Demikhova N, Rudenko T, Demikhov A. Assessment of the lipid profile correction in patients with arterial hypertension and type 2 diabetes mellitus. Azer MJ, 1, 18–22, 2019. Search in Google Scholar

Christiansen E, Urban C, Merten N, Liebscher K, Karlsen KK, Hamacher A. Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes. J Med Chem 51, 7061–7064, 2008.10.1021/jm801017818947221 Search in Google Scholar

Conwell DL, Lee LS, Yadav D, Longnecker DS, Miller FH, Morteleet KJ. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas 43, 1143–1162, 2014.10.1097/MPA.0000000000000237543497825333398 Search in Google Scholar

Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55, 2565–2582, 2012.10.1007/s00125-012-2644-8401149922869320 Search in Google Scholar

Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart 41, 255–323, 2020. Search in Google Scholar

Degen AS, Krynytska IY, Kamyshnyi AM. Changes in the transcriptional activity of the entero-insular axis genes in streptozotocin-induced diabetes and after the administration of TNF-alpha non-selective blockers. Endocr Regul 54, 160–171, 2020.10.2478/enr-2020-001932857721 Search in Google Scholar

Demihova N, Lidiya C, Chernatska O, Mazur T, Aleksakhina T, Demikhov O. The relationship between lipid metabolism and the level of albuminuria with single nucleotide polymorphism -204A>C [rs 3808607] CYP7A1 gene in patients with type 2 diabetes mellitus and diabetic nephropathy. Rom J Diabet Nutr Metab Dis 26, 253–260, 2019.10.2478/rjdnmd-2019-0026 Search in Google Scholar

Frangioudakis G, Ye JM, Cooney GJ. Both saturated and n-6 polyunsaturated fat diets reduce phosphorylation of insulin receptor substrate-1 and protein kinase B in muscle during the initial stages of in vivo insulin stimulation. Endocrinology 146, 5596–5603, 2005.10.1210/en.2005-048116150913 Search in Google Scholar

Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y, Man Y, Wang S, Yang J, Li J. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 285, 29965–29973, 2010.10.1074/jbc.M110.128694294326120647313 Search in Google Scholar

Gorgisen G, Gulacar IM, Ozes ON. The role of insulin receptor substrate (IRS) proteins in oncogenic transformation. Cell Mol Biol (Noisy-le-grand), 63, 1–5, 2017.10.14715/cmb/2017.63.1.128234626 Search in Google Scholar

He J, Qiu LX, Wang MY. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet 131, 1235–1244, 2012.10.1007/s00439-012-1152-822371296 Search in Google Scholar

Hevko U, Kozak K, Krynytska I, Marushchak M. Diagnostic value of a complete blood count in type 2 diabetes mellitus and comorbidities. Arch Balk Medical Union 55, 601–607, 2020.10.31688/ABMU.2020.55.4.06 Search in Google Scholar

Hosseini S, Alipour M, Zakerkish M, Cheraghian B, Ghandil P. Effects of epigallocatechin gallate on total antioxidant capacity, biomarkers of systemic low-grade inflammation and metabolic risk factors in patients with type 2 diabetes mellitus: the role of FTO-rs9939609 polymorphism. Arch Med Sci 17, 2021.10.5114/aoms.2020.95903864149134900054 Search in Google Scholar

International Diabetes Federation. Diabetes facts & figures, 2019. (online) Available at: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. [Accessed 2020 Aug 21]. Search in Google Scholar

Kaiser AB, Zhang N, Van Der Pluijm W. Global prevalence of type 2 diabetes over the next ten years (2018–2028). Diabetes 67, 202, 2018.10.2337/db18-202-LB Search in Google Scholar

Kilpelainen TO, Zillikens MC, Stancakova A, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 43, 753–760, 2011. Search in Google Scholar

Kojta I, Chacinska M, Blachnio-Zabielska A. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance. Nutrients 12, 1305, 2020.10.3390/nu12051305728499832375231 Search in Google Scholar

Liu M, Wang L, Li X, Wu Y, Yin F, Liu J. Trilobatin ameliorates insulin resistance through IRS-AKT-GLUT4 signaling pathway in C2C12 myotubes and ob/ob mice. Chin Med 15, 110, 2020.10.1186/s13020-020-00390-2755253033062046 Search in Google Scholar

Marushchak М, Krynytska I, Mazur L, Klishch I, Gabor G, Antonyshyn I. The relationship between experimental alimentary obesity and hard tooth tissues mineralization. Jord Med J 51, 25–33, 2017.10.12816/0039753 Search in Google Scholar

Melikhova S, Shevcova V, Zujkova A, Kotova Ju. Studying of comorbid pathology at the 2 type diabetes as the metabolic syndrome. Russ Arch Int Med 8, 366–371, 2018.10.20514/2226-6704-2018-0-5-366-371 Search in Google Scholar

Marushchak M, Maksiv K, Krynytska I. ACE gene I/D polymorphism and arterial hypertension in patients with COPD. Pneumologia 68, 114–119, 2019.10.2478/pneum-2019-0039 Search in Google Scholar

Marushchak M, Hevko U, Krynytska I, Danylevych Y, Danchak S, Mazur L. Does comorbid obesity or chronic pancreatitis influence the choice and effectiveness of glucose-lowering therapy in type-2 diabetes patients? Arch Balk Med Union 56, 24–32, 2021.10.31688/ABMU.2021.56.1.03 Search in Google Scholar

Menting JG, Whittaker J, Margetts MB, et al. How insulin engages its primary binding site on the insulin receptor. Nature 493, 24–245, 2013.10.1038/nature11781379363723302862 Search in Google Scholar

Minchenko DO, Davydov VV, Budreiko OA, Moliavko OS, Kulieshova DK, Tiazhka OV, Minchenko OH. The expression of CCN2, IQSEC, RSPO1, DNAJC15, RIPK2, IL13RA2, IRS1, and IRS2 genes in blood of obese boys with insulin resistance. Fiziol Zh 61, 10–18, 2015.10.15407/fz61.01.01026040030 Search in Google Scholar

Piepoli MF, Hoes AW, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37, 2315–2381, 2016.10.1093/eurheartj/ehw106498603027222591 Search in Google Scholar

Posokhova K, Stechyshyn I, Krynytska I, Marushchak M, Birchenko I, Klishch I. Comparative study of the effect of various forms of quercetin on experimental diabetes. Rom J Diabet Nutr Metab Dis 25, 383–388, 2018.10.2478/rjdnmd-2018-0046 Search in Google Scholar

Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the preventing overweight using novel dietary strategies (POUNDS LOST) trial. Circulation 124, 563–571, 2011.10.1161/CIRCULATIONAHA.111.025767317118921747052 Search in Google Scholar

Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 41, 1110–1115, 2009.10.1038/ng.44319734900 Search in Google Scholar

Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375, 2267–2277, 2010.10.1016/S0140-6736(10)60408-4 Search in Google Scholar

Shalimova A. Association of IRS>1 gene polymorphism with violations of blood lipid spectrum in patients with essential hypertension and concomitant type 2 diabetes. Family Med 3, 102–104, 2015. Search in Google Scholar

Shu XO, Long J, Cai Q, et al. Identification of new genetic risk variants for type 2 diabetes. PLoS Genet 6, e1001127, 2010.10.1371/journal.pgen.1001127294073120862305 Search in Google Scholar

So WY, Ng MC, Lee SC, Sanke T, Lee HK, Chan JC. Genetics of type 2 diabetes mellitus. Hong Kong Med J 6, 69–76, 2000. Search in Google Scholar

Vassy JL, Hivert MF, Porneala B, Dauriz M, Florez JC, Dupuis J, Siscovick DS, Fornage M, Rasmussen-Torvik LJ, Bouchard C, Meigs JB. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 63, 2172–2182, 2014.10.2337/db13-1663403011424520119 Search in Google Scholar

Voloshin O, Glubochenko O Pankiv I, Glubochenko V, Malkovich N. Peculiarities of phytotherapy of diabetes mellitus through the prism of comorbidity and prevention of complications (review of literature). Int J Endocrinol 15, 258–267, 2019.10.22141/2224-0721.15.3.2019.172113 Search in Google Scholar

Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol 19, 654–672, 2018.10.1038/s41580-018-0044-8638050330104701 Search in Google Scholar

Yang X, Nath A, Opperman MJ, Chan C. The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Mol Biol Cell 21, 3449–3458, 2010.10.1091/mbc.e10-06-0481294748020685959 Search in Google Scholar

Yiannakouris N, Cooper JA, Shah S, et al. IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk. Nutr Metab Cardiovas Dis 22, 1024–1030, 2012.10.1016/j.numecd.2011.05.009365717921917432 Search in Google Scholar

Yousef AA, Behiry EG, Allah WMA, Hussien AM, Abdelmoneam AA, Imam MH, Hikal DM. IRS-1 genetic polymorphism (r.2963G>A) in type 2 diabetes mellitus patients associated with insulin resistance. Appl Clin Genet 11, 99–106, 2018. Search in Google Scholar

Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277, 50230–50236, 2002.10.1074/jbc.M20095820012006582 Search in Google Scholar

Zhang Y, Yang S, Zhang M, Wang Z, He X, Hou Y, Bai G. Glycyrrhetinic acid improves insulin-response pathway by regulating the balance between the Ras/MAPK and PI3K/Akt pathways. Nutrients 11, 604, 2019.10.3390/nu11030604647047330871060 Search in Google Scholar

Zhao Y, Biswas SK, Mcnulty PH, Kozak M, Jun JY, Segar L. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates. Am J Physiol Cell Physiol 300, 1375–1385, 2011.10.1152/ajpcell.00670.2008311862721325637 Search in Google Scholar

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14, 88–98, 2018.10.1038/nrendo.2017.15129219149 Search in Google Scholar

Zhuravleva L, Shekhovtsova Yu. Comorbidity of chronic pancreatitis and diabetes type 2: possible options of pharmacoteraphy. Practical Doctor 5, 21–25, 2016. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo